Skip to main content

Real-Time AI-Driven Decision Support Aids Catheter Ablation

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on May 7, 2025.

via HealthDay

WEDNESDAY, May 7, 2025 -- An artificial intelligence (AI)-driven model can significantly improve procedural safety in cardiac electrophysiology with real-time decision support, according to a study presented at the annual meeting of the Heart Rhythm Society, held from April 24 to 27 in San Diego.

Chih-Min Liu, M.D., Ph.D., from Taipei Veterans General Hospital in Taiwan, and colleagues developed the DeePRISM model using retrospective data from 110 patients with persistent atrial fibrillation (AF), incorporating deep learning and PRISM (Morphological Repetitiveness by Periodicity and Similarity) analysis to analyze intracardiac electrograms and predict AF termination sites during catheter ablation. An additional 37 patients with persistent AF were used to prospectively validate the model.

The researchers found that the DeePRISM model achieved strong performance in the independent test set with an area under the curve of 0.87 (sensitivity, 74.3 percent, specificity, 95.4 percent, overall accuracy, 95.4 percent). Roughly four in 10 patients (40.5 percent) achieved acute AF termination when undergoing DeePRISM-guided ablation. During a mean follow-up of 27.3 months, the DeePRISM group had significantly superior arrhythmia-free survival versus controls (70.3 versus 35.1 percent). Additionally, DeePRISM-guided ablation significantly reduced the risk for AF recurrence (hazard ratio, 0.10) without any periprocedural complications.

"With the introduction of the DeePRISM model, we are taking a significant step forward in the treatment of persistent atrial fibrillation," Liu said in a statement. "Our study shows that AI-driven, real-time analysis not only enhances the success of the procedure but also ensures patient safety, marking a promising advance in electrophysiology."

Press Release

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

CVD Mortality Varies Among Asian Indian, Chinese, Filipino Americans

MONDAY, Aug. 4, 2025 -- Cardiovascular risk factor and disease mortality varies significantly among Asian Indian, Chinese, and Filipino Americans, with Filipino Americans having...

Exercise-Based Cardiac Rehabilitation Aids Atrial Fibrillation

THURSDAY, July 31, 2025 -- Exercise-based cardiac rehabilitation (ExCR) shows clinical benefits in patients with atrial fibrillation (AF), according to a review published online...

Glipizide Linked to Highest MACE-4 Risk in Individuals With Type 2 Diabetes

MONDAY, July 28, 2025 -- For individuals with type 2 diabetes (T2D) and moderate cardiovascular risk treated with metformin, the risk for major adverse cardiovascular events is...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.